Skip to content
  • Sunday, 26 July 2026
  • 3:18 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • The Future of Patient Adherence Hinges on Flexible, Engaging, and Affordable Health Technologies
Pharmaceutical R&D

The Future of Patient Adherence Hinges on Flexible, Engaging, and Affordable Health Technologies

Teuku Ryan Jun 23, 2026 0

The pharmaceutical, biotech, and medtech industries are witnessing an unprecedented surge in innovations, offering patients access to treatments previously considered…

Read More
Pharmaceutical R&D

Jazz Pharmaceuticals and AbCellera Forge Strategic Alliance to Pioneer Novel T-cell Engaging Antibodies for Gastrointestinal and Solid Tumors

Teuku Ryan Jun 19, 2026 0

Jazz Pharmaceuticals and AbCellera have announced a significant preclinical research, option, and license agreement, poised to accelerate the discovery and…

Read More
Data Science & Bioinformatics

Unlocking the Power of Personal AI: Five Engaging Projects with OpenClaw

Evan Lee Salim Apr 6, 2026 0

The rapid evolution of artificial intelligence has ushered in a new era, moving beyond mere conversational chatbots to sophisticated AI…

Read More
Unraveling the Tangled Genetic Tapestry of Our Most Vital CropsDrexel University Researchers Engineer High-Conductivity One-Dimensional MXene Nanoscrolls for Advanced Energy and Quantum ApplicationsRethinking Evidence Generation for Ultra-Rare DiseasesCornell University Researchers Develop Grain of Salt Sized Neural Implant for Long Term Wireless Brain Monitoring
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ